AQUINOX PHARMACEUTICALS INC - COM (AQXP)

CUSIP: 03842B101

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
21,492,427
Share change
+289,007
Total reported value
$252,766,200
Price per share
$11.76
Number of holders
51
Value change
+$3,239,114
Number of buys
27
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q4 2017

As of 31 Dec 2017, AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,492,427 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, BlackRock Inc., GOLDMAN SACHS GROUP INC, Ghost Tree Capital, LLC, Point72 Asset Management, L.P., Boxer Capital, LLC, Vanguard Group Inc, and Alyeska Investment Group, L.P.. This page lists 51 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.